Try our mobile app

Published: 2023-11-08 06:01:30 ET
<<<  go to SPNS company page
EX-99.1 2 ea187838ex99-1_sapiensinter.htm SAPIENS REPORTS THIRD QUARTER 2023 FINANCIAL RESULTS

Exhibit 99.1

 

 

Sapiens Reports Third Quarter 2023 Financial Results

 

November 8, 2023 – Sapiens International Corporation, (NASDAQ and TASE: SPNS), a leading global provider of software solutions for the insurance industry, today announced its financial results for the third quarter ended September 30, 2023.

 

Summary Results for Third Quarter 2023 (USD in millions, except per share data)

 

   GAAP       Non-GAAP     
   Q3 2023   Q3 2022   % Change   Q3 2023   Q3 2022   % Change 
Revenue  $130.7   $119.0    9.8%  $130.8   $119.0    9.9%
Gross Profit  $56.0   $50.3    11.3%  $59.3   $53.5    10.7%
Gross Margin   42.8%   42.2%   60 bps    45.3%   45.0%   30 bps  
Operating Income  $20.3   $16.6    22.4%  $24.1   $20.9    15.1%
Operating Margin   15.5%   13.9%   160 bps    18.4%   17.6%   80 bps 
Net Income (*)  $15.9   $13.4    18.5%  $19.1   $16.9    13.1%
Diluted EPS  $0.28   $0.24    16.7%  $0.34   $0.30    13.3%

 

(*)Attributable to Sapiens’ shareholders

 

Roni Al-Dor, President and CEO of Sapiens, stated, “In the third quarter, we delivered strong revenues growth, of 10% to reach $130.8 million, driven by growth in our European and North America regions.

 

New logo win momentum has been strong throughout the year and existing customer product expansion has also been healthy.

 

This quarter also saw further expansion in our operating margin to 18.4%, resulting in an operating profit of $24.1 million. As we have consistently done throughout 2023, we remained committed to executing our growth strategy across diverse regions and product categories. With a multitude of growth drivers at our disposal, including regional and product diversification, Sapiens is strategically positioned for both future growth and profitability.”

 

Mr. Al-Dor continued, “We are heartbroken by the war taking place in Israel, and our thoughts are with all who are impacted by these brutal terror attacks. Despite the recent tragic events in Israel, our global business has continued to run smoothly, thanks to our dedicated global employee base. During this period, we have received support from our customers, prospects, the investment community, partners, and employees. We deeply appreciate the support during this challenging time.”

 

1

 

  

In commenting on the company’s outlook, Mr. Al-Dor stated, “Today, we are reiterating our 2023 full-year Non-GAAP revenue guidance of $511 – $516 million and increasing our full year 2023 Non-GAAP operating margin guidance from 18.0% – 18.2% to a range of 18.2% - 18.3%.”

 

Management will host a conference call and webcast today, November 8, 2023 at 9:30 a.m. Eastern Time (4:30 pm in Israel) to review and discuss Sapiens’ results.

 

Please call the following numbers (at least 10 minutes before the scheduled time) to participate:

 

North America (toll-free): + 1-888-642-5032; International: +972-3-918-0609; UK: 0-800-917-5108

 

The live webcast of the call can be accessed at: https://veidan.activetrail.biz/sapiensq3-2023. A replay of the call will be available one business day following the completion of the event at the same link for 90 days.

 

Non-GAAP Financial Measures

 

This press release contains the following non-GAAP financial measures: non-GAAP revenue, non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating income, non-GAAP operating margin, non-GAAP net income attributed to Sapiens shareholders, non-GAAP basic and diluted earnings per share, Adjusted EBITDA and Adjusted Free Cash-Flow.

 

Sapiens believes that these non-GAAP measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to Sapiens’ financial condition and results of operations. The Company’s management uses these non-GAAP measures to compare the Company’s performance to that of prior periods for trend analyses, for purposes of determining executive and senior management incentive compensation and for budgeting and planning purposes. These measures are used in financial reports prepared for management and in quarterly financial reports presented to the Company’s board of directors. The Company believes that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends, and in comparing the Company’s financial measures with other software companies, many of which present similar non-GAAP financial measures to investors.

 

2

 

 

Non-GAAP financial measures consist of GAAP financial measures adjusted to exclude: Valuation adjustment on acquired deferred revenue, amortization of capitalized software development and other intangible assets, capitalization of software development, stock-based compensation, compensation related to acquisition and acquisition-related costs, restructuring and cost reduction costs, and tax adjustments related to non-GAAP adjustments.

 

Management of the Company does not consider these non-GAAP measures in isolation, or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of these non-GAAP financial measures is that they exclude significant expenses and income that are required by GAAP to be recorded in the Company’s financial statements. In addition, they are subject to inherent limitations, as they reflect the exercise of judgment by management about which expenses and income are excluded or included in determining these non-GAAP financial measures.

 

To compensate for these limitations, management presents non-GAAP financial measures in connection with GAAP results. Sapiens urges investors to review the reconciliation of its non-GAAP financial measures to the comparable GAAP financial measures, which it includes in press releases announcing quarterly financial results, including this press release, and not to rely on any single financial measure to evaluate the Company’s business.

 

Reconciliation tables of the most comparable GAAP financial measures to the non-GAAP financial measures used in this press release are included with the financial tables of this release.

 

The Company defines Adjusted EBITDA as net profit, adjusted to eliminate valuation adjustment on acquired deferred revenue, stock-based compensation expense, depreciation and amortization, capitalization of software development costs, compensation expenses related to acquisition and acquisition-related costs, restructuring and cost reduction costs, financial expense (income), provision for income taxes and other income (expenses). These amounts are often excluded by other companies as well, in order to help investors understand the operational performance of their business.

 

The Company uses Adjusted EBITDA as a measurement of its operating performance, because it assists in comparing the operating performance on a consistent basis by removing the impact of certain non-cash and non-operating items. Adjusted EBITDA reflects an additional way of viewing aspects of the operations that the Company believes, when viewed with the GAAP results and the accompanying reconciliations to corresponding GAAP financial measures, provide a more complete understanding of factors and trends affecting its business. The Company uses Adjusted Free Cash-Flow as a measurement of its operating performance, and reconciles cash-flow from operating activities to Adjusted Free Cash-Flow, while reducing the amounts for capitalization of software development costs and capital expenditures. The Company adds back cash payments made for former acquisitions in respect of future performance targets and retention criteria as determined upon acquisition date of the respective acquired company, which were included in the cash-flow from operating activities. We believe that Adjusted Free Cash-Flow is useful in evaluating our business, because Adjusted Free Cash-Flow reflects the cash surplus available to fund the expansion of our business.

 

3

 

 

About Sapiens

 

Sapiens International Corporation (NASDAQ and TASE: SPNS) empowers the financial sector, with a focus on insurance, to transform and become digital, innovative, and agile. With more than 40 years of industry expertise, Sapiens’ cloud-based SaaS insurance platform offers pre-integrated, low-code capabilities across core, data and digital domains to accelerate our customers’ digital transformation. Serving over 600 customers in more than 30 countries, Sapiens offers insurers across property and casualty, workers’ compensation, and life insurance markets the most comprehensive set of solutions, from core to complementary, including Reinsurance, Financial & Compliance, Data & Analytics, Digital, and Decision Management.  For more information visit www.sapiens.com or follow us on LinkedIn.

 

Investor and Media Contact

 

Yaffa Cohen-Ifrah

Chief Marketing Officer and Head of

Investor Relations, Sapiens

Yaffa.cohen-ifrah@sapiens.com

+1 917-533-4782 

Investor Contacts

 

Kimberly Rogers
Managing Director, Hayden IR
+1 541-904-5075
kim@HaydenIR.com

 

 

4

 

 

Forward Looking Statements

 

Certain matters discussed in this press release are forward-looking statements within the meaning of Section 27A of the Securities Act, Section 21E of the Exchange Act and the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, and are based on our beliefs, assumptions and expectations, as well as information currently available to us. Such forward-looking statements may be identified by the use of the words “anticipate,” “believe,” “estimate,” “expect,” “may,” “will,” “plan” and similar expressions. Such statements reflect our current views with respect to future events and are subject to certain risks and uncertainties. There are important factors that could cause our actual results, levels of activity, performance or achievements to differ materially from the results, levels of activity, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to: the degree of our success in our plans to leverage our global footprint to grow our sales; the degree of our success in integrating the companies that we have acquired through the implementation of our M&A growth strategy; the lengthy development cycles for our solutions, which may frustrate our ability to realize revenues and/or profits from our potential new solutions; our lengthy and complex sales cycles, which do not always result in the realization of revenues; the degree of our success in retaining our existing customers or competing effectively for greater market share; difficulties in successfully planning and managing changes in the size of our operations; the frequency of the long-term, large, complex projects that we perform that involve complex estimates of project costs and profit margins, which sometimes change mid-stream; the challenges and potential liability that heightened privacy laws and regulations pose to our business; occasional disputes with clients, which may adversely impact our results of operations and our reputation; various intellectual property issues related to our business; potential unanticipated product vulnerabilities or cybersecurity breaches of our or our customers’ systems; risks related to the insurance industry in which our clients operate; risks associated with our global sales and operations, such as changes in regulatory requirements, wide-spread viruses and epidemics like the recent novel coronavirus pandemic, which adversely affected our results of operations, or fluctuations in currency exchange rates; and risks related to our principal location in Israel and our status as a Cayman Islands company. While we believe such forward-looking statements are based on reasonable assumptions, should one or more of the underlying assumptions prove incorrect, or these risks or uncertainties materialize, our actual results may differ materially from those expressed or implied by the forward-looking statements. Please read the risks discussed under the heading “Risk Factors” in our most recent Annual Report on Form 20-F, which we filled with the SEC on March 31, 2022, in order to review conditions that we believe could cause actual results to differ materially from those contemplated by the forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that future results, levels of activity, performance and events and circumstances reflected in the forward-looking statements will be achieved or will occur. Except as required by law, we undertake no obligation to update publicly any forward-looking statements for any reason, to conform these statements to actual results or to changes in our expectations.

 

5

 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

 

CONDENSED CONSOLIDATED STATEMENT OF INCOME

U.S. dollars in thousands (except per share amounts)

  

   Three months ended    Nine months ended 
   September 30,    September 30, 
   2023   2022   2023   2022 
   (unaudited)   (unaudited)   (unaudited)   (unaudited) 
                 
Revenue   130,705    118,996    383,725    355,273 
Cost of revenue   74,753    68,721    220,080    205,415 
                     
Gross profit   55,952    50,275    163,645    149,858 
                     
Operating expenses:                    
Research and development, net   16,028    14,804    47,391    43,405 
Selling, marketing, general and administrative   19,659    18,919    57,475    56,443 
Total operating expenses   35,687    33,723    104,866    99,848 
                     
Operating income   20,265    16,552    58,779    50,010 
                     
Financial and other expenses (income), net   551    (82)   2,310    2,038 
Taxes on income   3,710    2,893    10,627    8,342 
                     
Net income   16,004    13,741    45,842    39,630 
                     
Attributable to non-controlling interest   132    348    371    401 
                     
Net income attributable to Sapiens’ shareholders   15,872    13,393    45,471    39,229 
                     
Basic earnings per share   0.29    0.25    0.82    0.72 
                     
Diluted earnings per share   0.28    0.24    0.82    0.71 
                     
Weighted average number of shares outstanding used to compute basic earnings per share (in thousands)   55,397    55,124    55,251    55,109 
                     
Weighted average number of shares outstanding used to compute diluted earnings per share (in thousands)   55,813    55,581    55,657    55,595 

 

6

 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND SUBSIDIARIES

 

RECONCILIATION OF GAAP TO NON-GAAP RESULTS

U.S. dollars in thousands (except per share amounts)

 

   Three months ended   Nine months ended 
   September 30,   September 30, 
   2023   2022   2023   2022 
   (unaudited)   (unaudited)   (unaudited)   (unaudited) 
                 
GAAP revenue   130,705    118,996    383,725    355,273 
Valuation adjustment on acquired deferred revenue   55    23    165    69 
Non-GAAP revenue   130,760    119,019    383,890    355,342 
                     
GAAP gross profit   55,952    50,275    163,645    149,858 
Revenue adjustment   55    23    165    69 
Amortization of capitalized software   1,418    1,442    4,274    4,323 
Amortization of other intangible assets   1,835    1,806    5,531    5,446 
Non-GAAP gross profit   59,260    53,546    173,615    159,696 
                     
GAAP operating income   20,265    16,552    58,779    50,010 
Gross profit adjustments   3,308    3,271    9,970    9,838 
Capitalization of software development   (1,638)   (1,492)   (4,975)   (4,859)
Amortization of other intangible assets   1,074    1,269    3,234    3,668 
Stock-based compensation   1,038    1,141    2,960    3,201 
Acquisition-related costs *)   11    161    21    561 
Non-GAAP operating income   24,058    20,902    69,989    62,419 
                     
GAAP net income attributable to Sapiens’ shareholders   15,872    13,393    45,471    39,229 
Operating income adjustments   3,793    4,350    11,210    12,408 
Taxes on income   (585)   (872)   (1,738)   (2,489)
Non-GAAP net income attributable to Sapiens’ shareholders   19,080    16,871    54,943    49,148 

 

(*)Acquisition-related costs pertain to charges on behalf of M&A agreements related to future performance targets and retention criteria, as well as third-party services, such as tax, accounting and legal rendered until the acquisition date.

 

7

 

 

Adjusted EBITDA Calculation
U.S. dollars in thousands

 

   Three months ended   Nine months ended 
   September 30,   September 30, 
   2023   2022   2023   2022 
                 
GAAP operating profit   20,265    16,552    58,779    50,010 
                     
Non-GAAP adjustments:                    
Valuation adjustment on acquired deferred revenue   55    23    165    69 
Amortization of capitalized software   1,418    1,442    4,274    4,323 
Amortization of other intangible assets   2,909    3,075    8,765    9,114 
Capitalization of software development   (1,638)   (1,492)   (4,975)   (4,859)
Stock-based compensation   1,038    1,141    2,960    3,201 
Compensation related to acquisition and acquisition-related costs   11    161    21    561 
                     
Non-GAAP operating profit   24,058    20,902    69,989    62,419 
                     
Depreciation   719    1,134    2,750    3,208 
                     
Adjusted EBITDA   24,777    22,036    72,739    65,627 

 

Summary of NON-GAAP Financial Information
U.S. dollars in thousands (except per share amounts)

 

   Q3 2023   Q2 2023   Q1 2023   Q4 2022   Q3 2022 
                     
Revenues   130,760    128,354    124,776    119,486    119,019 
Gross profit   59,260    57,992    56,363    53,774    53,546 
Operating income   24,058    23,417    22,514    21,058    20,902 
Adjusted EBITDA   24,777    24,393    23,569    22,092    22,036 
Net income to Sapiens’ shareholders   19,080    18,610    17,253    18,022    16,871 
                          
Diluted earnings per share   0.34    0.33    0.31    0.32    0.30 

 

8

 

 

Non-GAAP Revenues by Geographic Breakdown
U.S. dollars in thousands

 

   Q3 2023   Q2 2023   Q1 2023   Q4 2022   Q3 2022 
                     
North America   54,848    52,116    50,371    50,801    49,555 
Europe   64,662    62,960    64,572    56,910    56,887 
Rest of the World   11,250    13,278    9,833    11,775    12,577 
                          
Total   130,760    128,354    124,776    119,486    119,019 

 

Non-GAAP Revenue breakdown

 

U.S. dollars in thousands

 

   Three months ended   Nine months ended 
   September 30,   September 30, 
   2023   2022   2023   2022 
                 
Software products and re-occurring post-production services (*)   87,356    74,950    251,757    222,539 
Pre-production implementation services (**)   43,404    44,069    132,133    132,803 
                     
Total Revenues   130,760    119,019    383,890    355,342 

 

   Three months ended   Nine months ended 
   September 30,   September 30, 
   2023   2022   2023   2022 
                 
Software products and re-occurring post-production services (*)   46,053    41,369    133,339    119,414 
Pre-production implementation services (**)   13,207    12,177    40,276    40,282 
                     
Total Gross profit   59,260    53,546    173,615    159,696 

 

 

   Three months ended   Nine months ended 
   September 30,   September 30, 
   2023   2022   2023   2022 
                 
Software products and re-occurring post-production services (*)   52.7%   55.2%   53.0%   53.7%
Pre-production implementation services (**)   30.4%   27.6%   30.5%   30.3%
                     
Gross Margin   45.3%   45.0%   45.2%   44.9%

 

(*)Software products and re-occurring post-production services include mainly term license, maintenance, cloud solutions, subscription, and post-production services. This revenue stream is a mix of recurring and re-occurring in nature.

 

(**)Pre-production implementation services include mainly implementation services before go-live, which are one-time in nature.

 

9

 

 

Adjusted Free Cash-Flow
U.S. dollars in thousands

 

   Q3 2023   Q2 2023   Q1 2023   Q4 2022   Q3 2022 
                     
Cash-flow from operating activities   3,988    14,603    22,188    14,430    4,405 
Increase in capitalized software development costs   (1,638)   (1,679)   (1,658)   (1,238)   (1,492)
Capital expenditures   (696)   (775)   (634)   (400)   (1,047)
Free cash-flow   1,654    12,149    19,896    12,792    1,866 
                          
Cash payments attributed to acquisition-related costs(*) (**)   -    -    30    1,100    - 
                          
Adjusted free cash-flow   1,654    12,149    19,926    13,892    1,866 

 

(*)Included in cash-flow from operating activities

 

(**)Acquisition-related payments pertain to payments on behalf of M&A agreements related to future performance targets and retention criteria, as well as third-party services, such as, tax, accounting and legal rendered until the acquisition date.


 

10

 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

 

CONDENSED CONSOLIDATED BALANCE SHEET

U.S. dollars in thousands

 

   September 30,   December 31, 
   2023   2022 
   (unaudited)   (unaudited) 
         
ASSETS        
         
CURRENT ASSETS        
Cash and cash equivalents   97,061    160,285 
Short-term bank deposit   75,400    20,000 
Trade receivables, net and unbilled receivables   98,833    93,382 
Other receivables and prepaid expenses   19,093    11,640 
Total current assets   290,387    285,307 
           
LONG-TERM ASSETS          
Property and equipment, net   11,046    12,021 
Severance pay fund   3,383    3,996 
Goodwill and intangible assets, net   305,225    319,661 
Operating lease right-of-use assets   23,713    33,688 
Other long-term assets   16,399    13,671 
Total long-term assets   359,766    383,037 
           
TOTAL ASSETS   650,153    668,344 
           
LIABILITIES AND EQUITY          
           
CURRENT LIABILITIES          
Trade payables   8,508    9,415 
Current maturities of Series B Debentures   19,796    19,796 
Accrued expenses and other liabilities   73,258    76,962 
Current maturities of operating lease liabilities   6,919    9,063 
Deferred revenue   31,120    30,720 
Total current liabilities   139,601    145,956 
           
LONG-TERM LIABILITIES          
Series B Debentures, net of current maturities   39,526    59,275 
Deferred tax liabilities   10,716    11,363 
Other long-term liabilities   12,499    13,312 
Long-term operating lease liabilities   21,006    28,432 
Redeemable non-controlling interest   82    89 
Accrued severance pay   7,004    7,063 
Total long-term liabilities   90,833    119,534 
           
EQUITY   419,719    402,854 
           
TOTAL LIABILITIES AND EQUITY   650,153    668,344 

 

11

 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

 

CONSOLIDATED STATEMENT OF CASH FLOW
U.S. dollars in thousands

 

   For the Nine months ended
September 30,
 
   2023   2022 
   (unaudited)   (unaudited) 
Cash flows from operating activities:        
Net income   45,842    39,630 
Reconciliation of net income to net cash provided by operating activities:          
Depreciation and amortization   15,789    16,645 
Accretion of discount on Series B Debentures   47    61 
Capital loss from sale of property and equipment   83    27 
Stock-based compensation related to options issued to employees   2,960    3,201 
           
Net changes in operating assets and liabilities, net of amount acquired:          
Increase in trade receivables, net and unbilled receivables   (8,698)   (21,386)
Decrease in deferred tax liabilities, net   (1,410)   (978)
Decrease (increase) in other operating assets   (4,107)   5,475 
Increase (decrease) in trade payables   (616)   7,527 
Decrease in other operating liabilities   (10,110)   (15,122)
Increase (decrease) in deferred revenues   363    (5,686)
Increase in accrued severance pay, net   636    (44)
Net cash provided by operating activities   40,779    29,350 
           
Cash flows from investing activities:          
Purchase of property and equipment   (2,145)   (2,334)
Investment in deposits   (55,379)   (133)
Proceeds from sale of property and equipment   40    31 
Payments for business acquisitions, net of cash acquired   -    (3,467)
Capitalized software development costs   (4,975)   (4,859)
Acquisition of intellectual property   (177)   - 
Net cash used in investing activities   (62,636)   (10,762)
           
Cash flows from financing activities:          
Proceeds from employee stock options exercised   4,755    - 
Distribution of dividend   (28,144)   (38,579)
Repayment of Series B Debenture   (19,796)   (19,796)
Dividend to non-controlling interest   (47)   - 
Net cash used in financing activities   (43,232)   (58,375)
           
Effect of exchange rate changes on cash and cash equivalents   1,865    (3,540)
           
Decrease in cash and cash equivalents   (63,224)   (43,327)
Cash and cash equivalents at the beginning of period   160,285    190,243 
           
Cash and cash equivalents at the end of period   97,061    146,916 

 

12

 

 

Debentures Covenants

 

As of September 30, 2023, Sapiens was in compliance with all of its financial covenants under the indenture for the Series B Debentures, based on having achieved the following in its consolidated financial results:

 

Covenant 1

 

§Target shareholders’ equity (excluding non-controlling interest): above $120 million.

 

§Actual shareholders’ equity (excluding non-controlling interest) equal to $417.2 million.

 

Covenant 2

 

§Target ratio of net financial indebtedness to net capitalization (in each case, as defined under the indenture for the Company’s Series B Debentures) below 65%.

 

§Actual ratio of net financial indebtedness to net capitalization equal to (36.68) %.

 

Covenant 3

 

§Target ratio of net financial indebtedness to EBITDA (accumulated calculation for the four last quarters) is below 5.5.

 

§Actual ratio of net financial indebtedness to EBITDA (accumulated calculation for the four last quarters) is equal to (1.19).

 

13